List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 275 studies with search of: Vomiting | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients
Conditions: Nausea;   Vomiting;   Terminally Ill
Intervention: Drug: Palonosetron
2 Recruiting Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
Conditions: Nausea;   Vomiting
Interventions: Drug: aprepitant;   Drug: Ondansetron
3 Recruiting Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dexamethasone;   Drug: dronabinol;   Drug: palonosetron hydrochloride;   Other: placebo
4 Recruiting A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)
Condition: Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC
Intervention: Drug: palonesetron
5 Recruiting Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Conditions: Head and Neck Cancer;   Nausea and Vomiting
Interventions: Drug: cisplatin;   Drug: dexamethasone;   Drug: fosaprepitant dimeglumine;   Drug: palonosetron hydrochloride;   Other: questionnaire administration;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
6 Recruiting Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Conditions: Anal Cancer;   Carcinoma of the Appendix;   Colorectal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Liver Cancer;   Nausea and Vomiting;   Pancreatic Cancer;   Peritoneal Cavity Cancer;   Small Intestine Cancer
Interventions: Drug: palonosetron hydrochloride;   Other: placebo
7 Recruiting Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Head and Neck Cancer;   Lymphoma;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Sarcoma
Interventions: Procedure: electroacupuncture therapy;   Procedure: management of therapy complications;   Procedure: nausea and vomiting therapy
8 Recruiting Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia
Conditions: Anaesthetics Gases, Xenon;   Anaesthetics Volatile, Sevoflurane;   Depth of Anaesthesia;   Postoperative Nausea;   Postoperative Vomiting
Interventions: Drug: Xenon;   Drug: Sevoflurane;   Drug: Dexamethasone;   Drug: NaCl;   Drug: Ondansetron
9 Recruiting Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: fosaprepitant dimeglumine;   Drug: systemic chemotherapy;   Other: survey administration;   Procedure: quality-of-life assessment
10 Recruiting Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing a Stem Cell Transplant
Conditions: Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Drug: ondansetron hydrochloride;   Other: survey administration;   Procedure: autologous hematopoietic stem cell transplantation
11 Recruiting B6 Treatment for Nausea and Vomiting in Pregnancy
Condition: Nausea and Vomiting Complain in Early Pregnancy
Intervention: Drug: vitamin B6
12 Not yet recruiting Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
Conditions: Nausea;   Vomiting
Interventions: Drug: Dexamethasone;   Drug: Aprepitant;   Drug: Placebo Dexamethasone
13 Recruiting Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy
Conditions: Vomiting;   Cisplatin;   Antineoplastic Combined Chemotherapy Protocols
Interventions: Drug: Placebo;   Drug: Gabapentin
14 Recruiting Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-Based Therapy
Condition: Colorectal Cancer
Intervention:
15 Recruiting Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Scopolamine
16 Recruiting Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Conditions: Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dexamethasone;   Drug: gabapentin;   Other: placebo
17 Recruiting A Randomized, Double-Blind Comparison of Oral Aprepitant Alone Versus Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Emend (Aprepitant) + Placebo;   Drug: Scopolamine + Emend (Aprepitant)
18 Not yet recruiting Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
Conditions: Solid Cancer;   Nausea and Vomiting
Intervention: Drug: Ramosetron, Aprepitant, Dexamethasone
19 Recruiting Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section
Conditions: Nausea;   Vomiting;   Cesarean Section
Interventions: Drug: Ephedrine [Synonyms: Ephedra, Ephedrinum];   Drug: Saline Placebo
20 Recruiting Blood Samples From Patients With Cancer Treated on a Clinical Trial to Control Nausea and Vomiting During Donor Stem Cell Transplant
Conditions: Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: medical chart review

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services